Virchows Archiv

, Volume 465, Issue 3, pp 339–350 | Cite as

Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing

  • Alberto Paniz-Mondolfi
  • Rajesh Singh
  • George Jour
  • Mandana Mahmoodi
  • A. Hafeez Diwan
  • Bedia A. Barkoh
  • Ronald Cason
  • Yve Huttenbach
  • Gustavo Benaim
  • John Galbincea
  • Rajyalakshmi Luthra
Original Article

Abstract

Cutaneous carcinosarcoma (CCS) is an extraordinarily rare neoplasm with a biphasic morphological pattern exhibiting both epithelial and sarcomatoid components. Although its histogenesis and biological aspects remain poorly understood, previous studies have postulated that this tumor may arise from single cancer stem cells which subsequently differentiate into distinct tumor lineages. In this study, we explored a wide array of mutational hot spot regions, through high-depth next-generation sequencing of 47 cancer-associated genes in order to assess the mutational landscape of these tumors and investigate whether the epithelial and mesenchymal components shared the same genetic signatures. Results from this study confirm that despite their striking phenotypic differences, both elements of this infrequent tumor indeed share a common clonal origin. Additionally, CCS appears to embrace a heterogeneous spectrum with specific underlying molecular signatures correlating with the defining epithelial morphotype, with those carcinosarcomas exhibiting a squamous cell carcinoma epithelial component exhibiting diverse point mutations and deletions in the TP53 gene, and those with a basal cell carcinoma morphotype revealing a more complex mutational landscape involving several genes. Also, the fact that our findings involve several targetable gene pathways suggests that the underlying molecular events driving the pathogenesis of CCS may represent future potential targets for personalized therapies.

Keywords

Carcinosarcoma Cutaneous Mutations Next-generation sequencing Stem cells Histogenesis 

Notes

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Dawson EK (1972) Carcinosarcoma of the skin. J R Coll Surg Edinb 17:243–246PubMedGoogle Scholar
  2. 2.
    Syme-Grant J, Syme-Grant NJ, Motta L, Howard Stevenson J, Evans AT (2006) Are primary cutaneous carcinosarcomas underdiagnosed? Five cases and a review of the literature. J Plast Reconstr Aesthet Surg 59:1402–1408PubMedCrossRefGoogle Scholar
  3. 3.
    Brasanac D, Boricic I, Todorovic V (2008) Tomanovic N (2008) Primary cutaneous carcinosarcoma: case report with expanded immunohistochemical analysis. Int J Dermatol 47:496–501PubMedCrossRefGoogle Scholar
  4. 4.
    Patel NK, McKee PH, Smith NP, Fletcher CD (1997) Primary metaplastic carcinoma (carcinosarcoma) of the skin: a clinicopathologic study of four cases and a review of the literature. Am J Dermatopathol 19:363–372PubMedCrossRefGoogle Scholar
  5. 5.
    Tran TA, Muller S, Chaudahri PJ, Carlson JA (2005) Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis. J Cutan Pathol 32:2–11PubMedCrossRefGoogle Scholar
  6. 6.
    Bigby SM, Charlton A, Miller MV, Zwi LJ, Oliver GF (2005) Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature. J Cutan Pathol 32:141–147PubMedCrossRefGoogle Scholar
  7. 7.
    Rose RF, Merchant W, Stables GI, Lyon CL, Platt A (2008) Basal cell carcinoma with a sarcomatous component (carcinosarcoma): a series of 5 cases and a review of the literature. J Am Acad Dermatol 59:627–632PubMedCrossRefGoogle Scholar
  8. 8.
    Upjohn E, Braue A, Ryan A (2010) Primary cutaneous carcinosarcoma: dermoscopic and immunohistochemical features. Australas J Dermatol 51:26–28PubMedCrossRefGoogle Scholar
  9. 9.
    Smart CN, Pucci RA, Binder SW, Cassarino DS (2009) Cutaneous carcinosarcoma with myoepithelial differentiation: immunohistochemical and cytogenetic analysis of a case presenting in an unusual location. Am J Dermatopathol 31:715–717PubMedCrossRefGoogle Scholar
  10. 10.
    Kantrow SM, Boyd AS (2007) Primary cutaneous metaplastic carcinoma: report of a case involving angiosarcoma. Am J Dermatopathol 29:270–273PubMedCrossRefGoogle Scholar
  11. 11.
    Mc Menamin ME, Goh SG, Poblet E, Gostelow BE, Robson A, Calonje E (2006) Sarcomatoid basal cell carcinoma-predilection for osteosarcomatous differentiation: a series of 11 cases. Am J Surg Pathol 30:1299–1308PubMedCrossRefGoogle Scholar
  12. 12.
    Luzar B, Perković T (2006) Cutaneous carcinosarcoma-basal cell carcinoma with osteosarcoma. J Cutan Pathol 33:591–592PubMedCrossRefGoogle Scholar
  13. 13.
    Ram R, Saadat P, Peng D, Vadmal M (2005) Case report and literature review: primary cutaneous carcinosarcoma. Ann Clin Lab Sci 35:189–194PubMedGoogle Scholar
  14. 14.
    Chiyoda T, Tsuda H, Tanaka H, Kataoka F, Nomura H, Nishimura S, Takano M, Susumu N, Saya H, Aoki D (2012) Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma? Genes, Chromosomes Cancer 51:229–239PubMedCrossRefGoogle Scholar
  15. 15.
    Ambrosini-Spaltro A, Vaira V, Braidotti P, Rovati MPL, Ferrero S, Bosari S (2006) Carcinosarcoma of the colon: report of a case with morphological, ultrastructural and molecular analysis. BMC Cancer 6:185PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Armstrong AB, Wang M, Eble JN, MacLennan GT, Montironi R, Tan PH, Lopez-Beltran A, Zhang S, Baldridge LA, Spartz H, Cheng L (2009) TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 22:113–118PubMedCrossRefGoogle Scholar
  17. 17.
    Sung MT, Wang M, MacLennan GT, Eble JN, Tan PH, Lopez-Beltran A, Montironi R, Harris JJ, Kuhar M, Cheng L (2007) Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 211:420–430PubMedCrossRefGoogle Scholar
  18. 18.
    Singh RR, Patel KP, Routbort M et al (2013) Clinical validation of a next generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn 15:607–622PubMedCrossRefGoogle Scholar
  19. 19.
    Routbort M, Patel KP, Singh RR et al (2012) OncoSeek-A versatile annotation and reporting system for next generation sequencing-based clinical mutation analysis of cancer specimens. J Mol Diagn 14:747Google Scholar
  20. 20.
    Xu F, Zou WB, Li XP et al (2013) Multiple carcinosarcomas of the esophagus and stomach. Oncol Lett 5:1017–1021PubMedCentralPubMedGoogle Scholar
  21. 21.
    Donnell CA, Pollock WJ, Sybers WA (1987) Thyroid carcinosarcoma. Arch Pathol Lab Med 12:1169–1172Google Scholar
  22. 22.
    Okudela K, Nakamura N, Sano J et al (2001) Thymic carcinosarcoma consisting of squamous cell carcinomatous and embryonal rhabdomyosarcomatous components. Report of a case and review of the literature. Pathol Res Pract 197:205–210PubMedCrossRefGoogle Scholar
  23. 23.
    Arend R, Doneza JA, Wright JD (2011) Uterine carcinosarcoma. Curr Opin Oncol 5:531–536Google Scholar
  24. 24.
    Haraguchi S, Fukuda Y, Sugisaki Y et al (1999) Pulmonary carcinosarcoma: immunohistochemical and ultrastructural Studies. Pathol Int 10:903–908CrossRefGoogle Scholar
  25. 25.
    Wick MR, Swanson PE (1993) Carcinosarcomas: current perspectives and a histological review of nosological concepts. Semin Diagn Pathol 10:118–127PubMedGoogle Scholar
  26. 26.
    El Harroudi T, Ech-Charif S, Amrani M et al (2010) Primary carcinosarcoma of the skin. J Hand Microsurg 2:79–81PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Biernat W, Kordek R, Liberski PP et al (1996) Carcinosarcoma of the skin: case report and literature review. Am J Dermatopathol 18:614–619PubMedCrossRefGoogle Scholar
  28. 28.
    Brown TJ, Tschen JA (1999) Primary carcinosarcoma of the skin: report of a case and review of the literature. Dermatol Surg 25:498–500PubMedCrossRefGoogle Scholar
  29. 29.
    Hanly MG, Allsbrook WC, Pantazis CG et al (1994) Pilomatrical carcinosarcoma of the cheek with subsequent pulmonary metastases. A case report. Am J Dermatopathol 16:196–200PubMedCrossRefGoogle Scholar
  30. 30.
    McKee PH, Fletcher CD, Stavrinos P et al (1990) Carcinosarcoma arising in eccrine spiradenoma. A clinicopathologic and immunohistochemical study of two cases. Am J Dermatopathol 12:335–343PubMedCrossRefGoogle Scholar
  31. 31.
    McCluggage WG, Fon LJ, O'Rourke D et al (1997) Malignant eccrine spiradenoma with carcinomatous and sarcomatous elements. J Clin Pathol 50:871–873PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Meriggi F, Tagliabò R, Morone G et al (1989) The potential malignancy of eccrine spiradenoma. Ital J Surg Sci 19:265–268PubMedGoogle Scholar
  33. 33.
    Mori O, Hachisuka H, Sasai Y (1990) Proliferating trichilemmal cyst with spindle cell carcinoma. Am J Dermatopathol 12:479–484PubMedCrossRefGoogle Scholar
  34. 34.
    Plumb SJ, Stone MS (2002) Proliferating trichilemmal tumor with a malignant spindle cell component. J Cutan Pathol 29:506–509PubMedCrossRefGoogle Scholar
  35. 35.
    Quay SC, Harrist TJ, Mihm MC Jr (1981) Carcinosarcoma of the skin. Case report and review. J Cutan Pathol 8:241–246PubMedCrossRefGoogle Scholar
  36. 36.
    Schaefer IM, Enders C, Polten A et al (2011) Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. Am J Clin Pathol 135:579–586PubMedCrossRefGoogle Scholar
  37. 37.
    Geyer FC, Weigelt B, Natrajan R et al (2009) Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 220:562–573CrossRefGoogle Scholar
  38. 38.
    Santiago Pérez JT, Pérez Vázquez MR, Rivera Valdespino A et al (2005) Carcinosarcoma of the breast: a tumour with controversial histogenesis. Clin Transl Oncol 7:255–257PubMedCrossRefGoogle Scholar
  39. 39.
    Paniz Mondolfi AE, Jour G, Johnson M et al (2013) Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing. Hum Pathol 44:2853–2860PubMedCrossRefGoogle Scholar
  40. 40.
    Nelson MA, Einspahr JG, Alberts DS et al (1994) Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85:23–29PubMedCrossRefGoogle Scholar
  41. 41.
    Brash DE (2006) Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 154:8–10PubMedCrossRefGoogle Scholar
  42. 42.
    Xie J, Aszterbaum M, Zhang X et al (2001) A role of PDGFR alpha in basal cell carcinoma proliferation. Proc Natl Acad Sci U S A 98:9255–9259PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Yang CM, Hsieh HL, Yao CC et al (2009) Protein kinase C-delta transactivates platelet-derived growth factor receptor-alpha in mechanical strain-induced collagenase 3 (matrix metalloproteinase-13) expression by osteoblast-like cells. J Biol Chem 284:26040–26050PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Yang CM, Chien CS, Yao CC et al (2004) Mechanical strain induces collagenase-3 (MMP-13) expression in MC3T3-E1 osteoblastic cells. J Biol Chem 279:22158–22165PubMedCrossRefGoogle Scholar
  45. 45.
    Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276–1312PubMedCentralPubMedCrossRefGoogle Scholar
  46. 46.
    Donovan J, Abraham D, Norman J (2013) Platelet-derived growth factor signaling in mesenchymal cells. Front Biosci (Landmark Ed) 18:106–119CrossRefGoogle Scholar
  47. 47.
    Athar M, Tang X, Lee JL et al (2006) Hedgehog signalling in skin development and cancer. Exp Dermatol 15:667–677PubMedCrossRefGoogle Scholar
  48. 48.
    Daja-Grosjean L, Couvé-Privat S (2005) Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 225:181–192CrossRefGoogle Scholar
  49. 49.
    Li C, Chi S, He N et al (2004) IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. Oncogene 23:1608–1617PubMedCrossRefGoogle Scholar
  50. 50.
    Kaur P, Mulvaney M, Carlson JA (2006) Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis. Am J Dermatopathol 28:293–307PubMedCrossRefGoogle Scholar
  51. 51.
    Lin N, Moroi Y, Uchi H et al (2007) Significance of the expression of phosphorylated-STAT3, −AKT and -ERK-1/2 in several tumors of the epidermis. J Dermatol Sci 48:71–73PubMedCrossRefGoogle Scholar
  52. 52.
    Hafner C, Landthaler M, Vogt T (2010) Activation of the PI3K/AKT signaling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations. Exp Dermatol 19:e222–e227PubMedCrossRefGoogle Scholar
  53. 53.
    Hafner C, Houben R, Baeurle A et al (2012) Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One 7:e31255PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Hafner C, López-Knowles E, Luis NM et al (2007) Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A 104:13450–13454PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Groesser L, Herschberger E, Landthaler M et al (2012) FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis. Br J Dermatol 166:784–788PubMedCrossRefGoogle Scholar
  56. 56.
    Miranda LQ, Fracaroli TS, Fonseca JC et al (2013) Analysis of mutations in the PIK3CA and FGFR3 genes in verrucous epidermal nevus. An Bras Dermatol 88:36–38PubMedCentralPubMedCrossRefGoogle Scholar
  57. 57.
    Matsuda S, Nakanishi A, Wada Y et al (2013) Roles of PI3K/AKT/PTEN pathway as a target for pharmaceutical therapy. Open Med Chem J 7:23–29PubMedCentralPubMedCrossRefGoogle Scholar
  58. 58.
    Almendro V, Marusyk A, Polyak K (2013) Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol: Mech Dis 8:277–302CrossRefGoogle Scholar
  59. 59.
    Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Eng J Med 366:883–892CrossRefGoogle Scholar
  60. 60.
    Polyak K (2011) (2011) Heterogeneity in breast cancer. J Clin Invest 121:3786–3788PubMedCentralPubMedCrossRefGoogle Scholar
  61. 61.
    Bonavia R, Inda MM, Cavenee WK (2011) Heterogeneity maintenance in Glioblastoma: a social network. Cancer Res 71:4055–4060PubMedCentralPubMedCrossRefGoogle Scholar
  62. 62.
    Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805:105PubMedCentralPubMedGoogle Scholar
  63. 63.
    Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318PubMedCrossRefGoogle Scholar
  64. 64.
    Iwatsuki M, Mimori K, Yokobori T et al (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101:293–299PubMedCrossRefGoogle Scholar
  65. 65.
    Yanhia H, Xinchun J (2007) The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis. Clin Chim Acta 383:51–56CrossRefGoogle Scholar
  66. 66.
    Smith A, Teknos TN, Pan Q (2013) Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 49:287–292PubMedCentralPubMedCrossRefGoogle Scholar
  67. 67.
    Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27:6920–6929PubMedCentralPubMedCrossRefGoogle Scholar
  68. 68.
    Hugo H, Ackland ML, Blick T et al (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213:374–383PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Alberto Paniz-Mondolfi
    • 1
    • 2
  • Rajesh Singh
    • 3
  • George Jour
    • 4
  • Mandana Mahmoodi
    • 5
  • A. Hafeez Diwan
    • 1
  • Bedia A. Barkoh
    • 3
  • Ronald Cason
    • 3
  • Yve Huttenbach
    • 1
  • Gustavo Benaim
    • 6
  • John Galbincea
    • 3
  • Rajyalakshmi Luthra
    • 3
  1. 1.Department of Pathology and ImmunologyBaylor College of MedicineHoustonUSA
  2. 2.Departments of Biochemistry and DermatopathologyFundación Jacinto Convit (SAIB/IVSS) & Universidad de Los Andes (ULA)Caracas/MéridaVenezuela
  3. 3.Molecular Diagnostics LaboratoryThe University of Texas MD Anderson Cancer CenterHoustonUSA
  4. 4.Department of Anatomic PathologyUniversity of Washington Medical CenterSeattleUSA
  5. 5.Department of DermatopathologyMiraca Life Sciences Research Institute & Tufts University School of MedicineBostonUSA
  6. 6.Laboratorio de Señalización Celular y Bioquímica de ParásitosInstituto de Estudios Avanzados (IDEA)CaracasVenezuela

Personalised recommendations